The dietary pigment curcumin reduces endothelial tissue factor gene expression by inhibiting binding of AP-1 to the DNA and activation of NF-κB

Thrombosis and Haemostasis

Volumn 77, Issue 4, 1997, Pages 772-782

  Bierhaus, Angelika ^a,e   Zhang, Youming ^a   Quehenberger, Peter ^b   Luther, Thomas ^c   Haase, Michael ^c   Müller, Martin ^c   Mackman, Nigel ^d   Ziegler, Reinhard ^a   Nawroth, Peter P ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF VIENNA   (Austria)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^d SCRIPPS RESEARCH INSTITUTE   (United States)

^e Universitaetsklinikum Heidelberg   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CURCUMIN; DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; THROMBOPLASTIN; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; AORTA; ARTICLE; BLOOD CLOTTING; CATTLE; CONTROLLED STUDY; DRUG MECHANISM; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; NONHUMAN; PLASMID; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DNA BINDING; VASCULAR ENDOTHELIUM;

EID: 0030939425     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1656049     Document Type: Article

References (69)

1. Collins T. Endothelial nuclear factor-kappa B and the initiation of the atherosclerotic lesion. Lab Invest 1993; 68: 499-508.
2. Liao F, Andalibi A, deBeer FC, Fogelman AM, Lusis AJ. Genetic control of inflammatory gene induction and NF-kappa B-like transcription factor activation in response to an atherogenic diet in mice. J Clin Invest 1993; 91: 2572-9.
3. Henning B, Diana JN, Toborek M, Mc Clain CJ. Influence of nutrients and cytokines on endothelial cell metabolism. J Am Coll Nutr 1994; 13; 224-31.
4. Read MA, Whitley MZ, Williams AJ, Collins T. NF-kappa B and I kappa B alpha: an inducible regulatory system in endothelial activation. J Exp Med 1994; 179: 503-12.
5. Sernau T, Bierhaus A, Tritschler T, Ziegler R, Wahl P, Nawroth PP. Thioctic acid prevents AGE mediated Tissue Factor induction by blocking translocation of NF-κB in vitro and in vivo. Ann of Hematol 1995; 70: A77, 305.
6. Wautier JL, Wautier MP, Schmidt AM, Anderson GM, Hori O, Zoukourian C, Capron L, Chappey O, Yan SD, Brett J et al. Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: a link between surface-associated AGEs and diabetic complications. Proc Natl Acad Sci USA 1994; 91: 7742-6.
7. Bierhaus A, Hemmer C, Mackman N, Kutob R, Ziegler R, Dietrich M, Nawroth PP. Antiparasitic treatment of patients with p. falciparum malaria reduces the ability of patients serum to induce tissue factor by decreasing NF-κB activation. Thromb Haemost 1995; 73: 3948.
8. Bierman EL. George Lyman Duff Memorial Lecture. Atherogenesis in diabetes. Arterioscler Thromb 1992; 12: 647-56.
9. Mohanty S, Mishra SK, Das BS, Satpathy SK, Mohanty D, Patnaik JK, Bose TK. Altered plasma lipid pattern in falciparum malaria. Ann Trop Med Parasitol 1992; 86: 601-6.
10. Gey KF, Moser UK, Jordan P, Stahelin HB, Eichholzer M, Ludin E. Increased risk of cardiovascular disease at suboptimal plasma concentrations of essential antioxidants: an epidemiological update with special attention to carotene and vitamin C. Am J Clin Nutr 1993; 57: 787S-97S.
11. Gaziano JM, Manson JE, Buring JE, Hennekens CH. Dietary antioxidants and cardiovascular disease. Ann N Y Acad Sci 1992; 669: 249-58.
12. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC. Vitamin E consumption and the risk of coronary heart disease in men [see comments]. N Engl J Med 1993; 328: 1450-6.
13. Steinberg D. Antioxidant vitamins and coronary heart disease [editorial; comment]. N Engl J Med 1993; 328: 1487-9.
14. 2 and antioxidants have opposite effects on activation of NF-kappa B and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. Embo J 1993; 12: 2005-15.
15. Meyer M, Pahl H, Baeuerle PA. Regulation of the transcription factors NF-κB and AP-1 by redox changes. Chem Biol Interact 1994; 91: 94-100.
16. Schenk H, Klein M, Erdbrugger W, Droge W, Schulze-Osthoff K. Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NF-kappa B and AP-1. Proc Natl Acad Sci USA 1994; 91: 1672-6.
17. Bierhaus A, Zhang Y, Deng Y, Mackman N, Quehenberger P, Haase M, Luther T, Müller M, Bohrer H, Greten J, Martin E, Baeuerle PA, Waldherr R, Kisiel W, Ziegler R, Stern DM, Nawroth PP. Mechanism of the TNFα mediated induction of endothelial tissue factor. J Biol Chem 1995; 270: 26419-32.
18. Mackman N, Fowler BJ, Edgington TS, Morrissey JH. Functional analysis of the human tissue factor promoter and induction by serum. Proc Natl Acad Sci USA 1990; 87: 2254-8.
19. Mackman N. Protease inhibitors block lipopolysaccharide induction of tissue factor gene expression in human monocytic cells by preventing activation of c-Rel/p65 heterodimers. J Biol Chem 1994; 269: 26363-7.
20. Oeth PA, Parry GC, Kunsch C, Nantermet P, Rosen CA, Mackman N. Lipopolysaccharide induction of tissue factor gene expression in monocytic cells is mediated by binding of c-Rel/p65 heterodimers to a kappa B-like site. Mol Cell Biol 1994; 14: 3772-81.
21. Parry GC, Mackman N. A set of inducible genes expressed by activated human monocytic and endothelial cells contain kappa B-like sites that specifically bind c-Rel-p65 heterodimers. J Biol Chem 1994; 269: 20823-5.
22. Mackman N. Regulation of the tissue factor gene. FASEB J 1995; 9: 883-9.
23. Parry GCN, Mackman N. Transcriptional regulation of Tissue Factor expression in human endothelial cells. Arterioscl Thromb Vasc Biol 1995; 15: 612-21.
24. Moll T, Czyz M, Holzmüller H, Hofer-Warbinek R, Wagner E, Winkler H, Bach FH, Hofer E. Regulation of the Tissue Factor promotor in endothelial cells. J Biol Chem 1995; 270: 3849-57.
25. Quehenberger P, Greten J, v-Riedesel J, Ziegler R, Wahl P, Speiser W, Bierhaus A, Nawroth PP. Endothelin-1 is under the control of the transcription factors p50/p65 (NF-κB) and AP-1. Ann of Hematol 1995; 70: A53, 211 (abstract).
26. van-de-Stolpe A, Caldenhoven E, Stade BG, Koenderman L, Raaijmakers JA, Johnson JP, van-der-Saag PT. 12-O-tetradecanoylphorbol-13-acetate- and tumor necrosis factor alpha-mediated induction of intercellular adhesion molecule-1 is inhibited by dexamethasone. Functional analysis of the human intercellular adhesion molecular-1 promoter. J Biol Chem 1994; 269: 6185-92.
27. Brach MA, Gruss HJ, Kaisho T, Asano Y, Hirano T, Herrmann F. Ionizing radiation induces expression of interleukin 6 by human fibroblasts involving activation of nuclear factor-kappa B. J Biol Chem 1993; 268: 8466-72.
28. Yasumoto K, Okamoto S, Mukaida N, Murakami S, Mai M, Matsushima K. Tumor necrosis factor alpha and interferon gamma synergistically induce interleukin 8 production in a human gastric cancer cell line through acting concurrently on AP-1 and NF-κB-like binding sites of the interleukin 8 gene. J Biol Chem 1992; 267: 22506-11.
29. Descheemaeker KA, Wyns S, Nelles L, Auwerx J, Ny T, Collen D. Interaction of AP-1-, AP-2-, and Sp1-like proteins with two distinct sites in the upstream regulatory region of the plasminogen activator inhibitor-1 gene mediates the phorbol 12-myristate 13-acetate response. J Biol Chem 1992; 267: 15086-91.
30. Joe B, Lokesh BR. Role of capsaicin, curcumin and dietary n-3 fatty acids in lowering the generation of reactive oxygen species in rat peritoneal macrophages. Biochim Biophys Acta 1994; 1224: 255-63.
31. Venkatesan N, Chandrakasan G. Modulation of cyclophosphamide-induced early lung injury by curcumin, an antiinflammatory antioxidant. Mol Cell Biochem 1995; 142: 79-87.
32. Chan MM. Inhibition of tumor necrosis factor by curcumin, a phytochemical. Biochem Pharmacol 1995; 49: 1551-6.
33. Singh S, Aggarwal BB. Activation of trancription factor NF-kappa B is suppressed by curcumin (diferulolmethane). J Biol Chem 1995; 270: 24995-5000.
34. Huang TS, Lee SC, Lin JK. Suppression of c-Jun/AP-1 activation by an inhibitor of tumor promotion in mouse fibroblast cells. Proc Natl Acad Sci USA 1991; 88: 5292-6.
35. Huang T, Kuo M, Lin J, Hsieh J. A labile hyperphosphorylated c-Fos protein is induced in mouse fibroblast cells treated with a combination of phorbol ester and anti-tumor promoter curcumin. Cancer Lett 1995; 96: 1-7.
36. Takeshita A, Chen Y, Watanabe A, Kitano S, Hanazawa S. TGF-beta induces expression of monocyte chemoattractant JE/monocyte chemo-attractant protein 1 via transcriptional factor AP-1 induced by protein kinase in osteoblastic cells. J Immunol 1995; 155: 419-26.
37. Hanazawa S, Takeshita A, Amano S, Semba T, Nirazuka T, Katoh H, Kitano S. Tumor necrosis factor-alpha induces expression of monocyte chemoattractant JE via fos and jun genes in clonal osteoblastic MC3T3-E1 cells. J Biol Chem 1993; 268: 9526-32.
38. Lu Y-P, Chang RL, Lou Y-R, Huang M-T, Newmark HL, Reuhl K, Conney AH. Effect of curcumin on 12-O-tetradecanoylphorbol-13-acetate and ultraviolet B light-induced expression of c-Jun and c-Fos in JB6 cells and in mouse epidermis. Carcinogenesis 1994; 15: 2362-70.
39. Dixit VM, Marks RM, Sarma V, Prochownik EV. The antimitogenic action of tumor necrosis factor is associated with increased AP-1/c-jun proto-oncogene transcription. J Biol Chem 1989; 264: 16905-9.
40. Collins T, Read AM, Neish AS, Whitley MZ, Thanos D, Maniatis T. Transcriptional regulation of endothelial cell adhesion molecules: NF-κB and cytokine-inducible enhancers. FASEB J 1995; 9: 899-909.
41. Schutze S, Potthoff K, Machleidt T, Berkovic D, Wiegmann K, Kronke M. TNF activates NF-kappa B by phosphatidylcholine-specific phospholipase C-induced "acidic" sphingomyelin breakdown. Cell 1992; 71: 765-76.
42. Collins T, Palmer HJ, Whitley M, Neish AS, Willims A. A common theme in endothelial activation. TCM 1993; 3: 92-7.
43. Bach R. Initiation of coagulation by tissue factor. CRC Crit Rev Biochem 1988; 23: 339-68.
44. Sassone-Corsi P, Ransone LJ, Lamph WW, Verma IM. Direct interaction between fos and jun nuclear oncoproteins: role of the leucine zipper domain. Nature 1988; 36: 692-5.
45. Lamph WW, Dwarki VJ, Ofir R, Montminy M, Verma IM. Negative and positive regulation by transcription factor cAMP response element-binding protein is modulated by phosphorylation. Proc Natl Acad Sci USA 1990; 87: 4320-4.
46. Bohmann D, Tjian R. Biochemical analysis of transcriptional activation by Jun: differential activity of c- and v-Jun. Cell 1989; 59: 709-17.
47. Scarpati EM, Wen D, Broze G, Miletich JP, Flandermayer RR, Siegel NR, Sadler E. Human Tissue Factor: c-DNA-sequence and chromosome localisation of the gene. Biochemistry 1987; 26: 5234-8.
48. Schwartz SM. Selection and characterization of bovine aortic endothelial cells. In vitro 1978; 14: 966-70.
49. Nawroth PP, Stern DM, Kaplan KL, Nossel HL. Prostacyclin production by perturbed bovine aortic endothelial cells in culture. Blood 1984; 64: 801-6.
50. Nawroth PP, Stern DM, Kisiel W, Bach R. Cellular requirements for tissue factor generation by bovine aortic endothelial cells in culture. Thromb Res 1985; 40: 677-91.
51. Greenberg NE, Ziff ME. Stimulation of 3T3 cells induce transcription of c-fos protooncogene. Nature 1984; 311: 433-8.
52. Andrews NC, Faller DV. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucl Acids Res 1991; 19: 2499.
53. Melton DA, Krieg PA, Rabdaliati MR, Maniatis T, Zinn K, Green MR. Efficient synthesis of biologically active RNA and RNA hybridisation probes from plasmids containing a bacteriophage SP6 promotor. Nucl Acids Res 1984; 12: 7035-56.
54. Schreiber E, Matthias P, Muller MM, Schaffner W. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res 1989; 17: 6419.
55. Srimal RC, Dhawan BN. Pharmacology of diferuloyl methane (curcumin), a non-steroidal antiinflammatory agent. J Pharm Pharmac 1973; 25: 447-52.
56. Yasni S, Imaizumi K, Nakamura M, Aimoto J, Sugano M. Effects of Curcuma xanthorrhiza Roxb. and curcuminoids on the level of serum and liver lipids, serum apolipoprotein A-I and lipogenic enzymes in rats. Food Chem Toxicol 1993; 31: 213-8.
57. Nagabhushan M, Bhide SV. Curcumin as an inhibitor of cancer. J Am Coll Nutr 1992; 11: 192-8.
58. Srivatava R, Diksit M, Srimal RC, Dhawan BN. Anti-thrombotic effects of curcumin. Thromb Res 1985; 40: 413-7.
59. Nagabhushan M, Amokar AJ, D'Souza AV, Bhide SV. Antimutagenicity of curcumins and related compounds: the structural requirements for the anti-mutagenicity of curcumins. Indian Drugs 1987; 25: 91-5.
60. Ammon HP, Safayhi H, Mack T, Sabieraj J. Mechanism of antiinflammatory actions of curcumine and boswellic acids. J Ethnopharmacol 1993; 38: 113-9.
61. Huang MT, Lou YR, Ma W, Newmark HL, Reuhl KR, Conney AH. Inhibitory effects of dietary curcumin on forestomach, duodenal, and colon carcinogenesis in mice. Cancer Res 1994; 54: 5841-7.
62. Ames BN, Shigenaga MK, Hagen TM. Oxidants, antioxidants and the degenerative diseases of aging. Proc Natl Acad Sci USA 1993; 90: 7915-22.
63. Karin M. Signal transduction and gene control. Curr Opin Cell Biol 1991; 3: 467-73.
64. Baeuerle PA, Henkel T. Function and activation of NF-κB in the immune system. Annu Rev Immun 1994; 12: 141-79.
65. Liu J-Y, Lin SJ, Lin J-K. Inhibitory effects of curcumin on protein kinase C activity induced by 12-O-tetradecanoylphorbol-13-acetate in NIH3T3 cells. Carcinogenesis 1993; 14: 857-61.
66. Boyle WJ, Smeal T, Defize LH, Angel P, Woodgett JR, Karin M, Hunter T. Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA binding activity. Cell 1991; 64: 573-84.
67. Brenner DA, O'Hara M, Angel P, Chojkier M, Karin M. Prolonged activation of jun and collagenase genes by tumor necrosis factor-alpha. Nature 1989; 337: 661-3.
68. de-Pater S, Katagiri F, Kijne J, Chua NH. bZIP proteins bind to a palindromic sequence without an ACGT core located in a seed-specific element of the pea lectin promoter. Plant J 1994; 6: 133-40.
69. Herrlich P, Ponta H, Rahmsdorf HJ. DNA damage-induced gene expression: signal transduction and relation to growth factor signaling. Rev Physiol Biochem Pharmacol 1992; 119: 187-223.